Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1440INDUSTRY 626NIH 183NETWORK 43OTHER_GOV 18UNKNOWN 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 71Genitourinary 59Thoracic 29Breast 14Lymphoid 12Other hematologic neoplasm 9Head & Neck 8Gynecologic 8Tumor-Agnostic 7Dermatologic 7CNS 4Other 3Plasma cell 2Myeloid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Blast Crisis 1

Interventions

Clofarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Interventional × Myeloid × Clear all
NCT00098033 2015-03-25

Investigation of Clofarabine in Acute Leukemias

FDA Office of Orphan Products Development

Phase 2 Completed
64 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡